Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A severe combined immunodeficiency characterized by being T cell-negative, B cell-positive and natural killer cell-positive and that has material basis in homozygous or compound heterozygous mutation in the IL7R gene on chromosome 5p13 or the CD45 gene on chromosome 1q31.
Features include always present findings: Decreased total T cell count, Gastroesophageal reflux, Chronic mucocutaneous candidiasis, and Recurrent otitis media. 15 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Digestive system | 4 | Diarrhea, Enlarged liver (hepatomegaly), Gastroesophageal reflux |
Blood and immune system | 4 | Severe combined immunodeficiency, Recurrent opportunistic infections, Failure to thrive secondary to recurrent infections |
Ears | 2 | Recurrent otitis media, Otitis media |
Lungs and breathing | 1 | Pneumonia |
Skin | 1 | Eczematoid dermatitis |
Growth and development | 1 | Failure to thrive secondary to recurrent infections |
IL7R encodes interleukin 7 receptor (459 aa). Receptor for interleukin-7. Also acts as a receptor for thymic stromal lymphopoietin (TSLP) Highest expression in Lung (89.7 TPM) and Small Intestine Terminal Ileum (57.7 TPM).
Immunodeficiency 104 is caused by mutations in the IL7R gene on chromosome 5.
IL7R is classified as a druggable target (Clinically Actionable, Druggable Genome, External Side Of Plasma Membrane, and Tyrosine Kinase categories) with score 17.4.
Genetic testing for IL7R is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for immunodeficiency 104 has been reported in the published literature.
Phenotype severity distribution: 4 always present features.
No clinical trials have been registered for immunodeficiency 104.
201 publications have been identified in PubMed for immunodeficiency 104. Kisho has analyzed 114 by research type. Research spans Epidemiology / Natural History (46%), Review / Meta-Analysis (21%), and Clinical Trial Publication (11%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 53 | 46% |
Research summaries | 24 | 21% |
Clinical study results | 12 | 11% |
Laboratory research | 10 | 9% |
Testing and diagnosis research | 7 | 6% |
Patient case studies | 4 | 4% |
New treatment approaches | 4 | 4% |
Atim SV (2026). [PMID: 41922481](https://pubmed.ncbi.nlm.nih.gov/41922481/). *Sci Rep*. [Epidemiology / Natural History]
Colson AE (2026). [PMID: 41429026](https://pubmed.ncbi.nlm.nih.gov/41429026/). *Ann Intern Med*. [Clinical Trial Publication]
Birn FH (2026). [PMID: 41422442](https://pubmed.ncbi.nlm.nih.gov/41422442/). *AIDS Behav*. [Diagnostic / Biomarker]
Moharrery T (2026). [PMID: 41406772](https://pubmed.ncbi.nlm.nih.gov/41406772/). *Sci Total Environ*. [Basic Science / Preclinical]
Kasujja FX (2026). [PMID: 41831847](https://pubmed.ncbi.nlm.nih.gov/41831847/). *Lancet*. [Clinical Trial Publication]
Metcalfe JZ (2026). [PMID: 40915311](https://pubmed.ncbi.nlm.nih.gov/40915311/). *Lancet Infect Dis*. [Clinical Trial Publication]
Vinciguerra M (2026). [PMID: 41771847](https://pubmed.ncbi.nlm.nih.gov/41771847/). *Cell Death Dis*. [Basic Science / Preclinical]
Miro JM (2026). [PMID: 41083105](https://pubmed.ncbi.nlm.nih.gov/41083105/). *Clin Microbiol Infect*. [Clinical Trial Publication]
Gaál Z (2026). [PMID: 41560547](https://pubmed.ncbi.nlm.nih.gov/41560547/). *Pediatr Blood Cancer*. [Diagnostic / Biomarker]
Li B (2026). [PMID: 42191971](https://pubmed.ncbi.nlm.nih.gov/42191971/). *Ann Hematol*. [Epidemiology / Natural History]
Data assembled from 6 of 12 sources · Last updated Sep 19, 2026, 12:58 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center